Schedule 13G ownership disclosure
AEON Biopharma, Inc.
Class A Common Stock, par value $0.0001 per share · CUSIP: 00791X100
Event date: 2025-03-31
- Filing-level shares
- 465,029.00
- Percent of class
- 4.11%
- L1 Capital Global Opportunities Master Fund, Ltd.
Shares: 465,029.00 · Class: 4.11%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001079973-25-000869
- Form type
- SCHEDULE 13G/A
- Filer
- AEON Biopharma, Inc.
- CIK
- CIK 1837607
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership